
Centaur Guernsey
Private equity owners rebrand KCI, Systagenix, LifeCell as Acelity
CeQur names medtech veteran as new CEO | Medtech personnel moves for the week of Apr. 14, 2014

CeQur gets new CEO from Becton Dickinson | Personnel Moves
April 11, 2014 by Arezu Sarvestani

Switzerland-based insulin delivery devices maker CeQur named medtech veteran Douglas Lawrence its new CEO, replacing James Peterson.
CeQur gets new CEO from Becton Dickinson | Personnel Moves



Switzerland-based insulin delivery devices maker CeQur named medtech veteran Douglas Lawrence its new CEO, replacing James Peterson.
Lawrence has spent more than 25 years in the medical device industry, most recently as vice president of the insulin injection business at Becton, Dickinson’s (NYSE:BDX) diabetes arm.
Kinetic Concepts, LifeCell, Systagenix trio posts red ink in Q4


The newly formed medtech alliance comprised of Kinetic Concepts, LifeCell and Systagenix posted collective figures that put the group in the red for Q4, a recent SEC filing shows.
Kinetic Concepts slips in Q3, losses widen for Systagenix, LifeCell triad


Sales took a minor hit for Kinetic Concepts during its 3rd quarter 2013, reporting as part of the Centaur Guernsey companies which now includes both LifeCell and Systagenix.